Is earlier better? Translating clinical evidence into individualised treatment decisions in advanced prostate cancer

ESMO 2018 Industry satellite symposium

Scientific Committee:

Eleni Efstathiou, USA
Boris Hadaschik, Germany  

Faculty:

Noel Clarke, UK
Karim Fizazi, France
Eric Small, USA  

Agenda:

13:00 - 13:15
The evolving landscape in advanced prostate cancer: current open questions
Boris Hadaschik, Germany

13:15 - 13:45 
Individualising treatments in mHSPC: an option or a must? 
Karim Fizazi, France and Noel Clark, UK

13:45 - 14:15
nmCRPC: is treatment really needed?
Eric Small, USA

14:15 - 14:30 A look to the future of prostate cancer treatment
Eleni Efstathiou, USA